This protocol is judged by an institutional evaluation board, an independent team that assessments any clinical trials involving people. If a research includes a Timetable I drug, after the board approves the protocol as moral, the scientists should make an application for an investigational new drug (IND) range from your FDA.If this is The 1st tim